Home Ingredients Tetrahydrocurcumin (THC, 'White Curcumin')
AntioxidantAnti-InflammatoryLiver Health

Tetrahydrocurcumin (THC, 'White Curcumin')

Curcuma longa (reduced metabolite)
Evidence Level
Limited
2 Clinical Trials
4 Documented Benefits
2/5 Evidence Score

Tetrahydrocurcumin (THC) — often called 'white curcumin' — is the colorless reduced metabolite of curcumin, generated in vivo by gut microbiota and intestinal enzymes that hydrogenate curcumin's two C=C double bonds, and also produced commercially via hydrogenation for direct supplement use. Preclinical work in diabetic and inflammatory models suggests THC retains and in some cases enhances curcumin's antioxidant activity while being more chemically stable and water-compatible than the parent compound. Despite frequent marketing claims about THC's superiority, the human clinical evidence base remains thin compared with standard curcumin or with branded bioavailability-enhanced curcumins, and most supporting data are preclinical. Honest positioning treats THC as a mechanistically interesting reduced metabolite with promising in vitro and animal data but limited human trial evidence.

Studied Dose Human dosing not well established; literature commonly references 100-500 mg/day equivalents, though robust human dose-finding RCTs are lacking.
Active Compound Tetrahydrocurcumin — the colorless, fully reduced metabolite of curcumin (saturated at both olefinic bonds); produced in vivo by gut microbiota or commercially via hydrogenation.

Benefits

Supports antioxidant defense (preclinical)

Tetrahydrocurcumin has been associated with strong free-radical scavenging activity and induction of endogenous antioxidant enzymes in preclinical models, including in streptozotocin-nicotinamide diabetic rat models, supporting an antioxidant-positioned ingredient. Human trial data are sparse.

Supported by Trial 1

Supports anti-inflammatory pathways (preclinical)

Preclinical comparisons of curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin, and turmerones report that THC differentially regulates anti-inflammatory and anti-proliferative responses, supporting a complementary anti-inflammatory positioning relative to standard curcumin.

Supported by Trial 2

Improved chemical stability versus curcumin

THC is colorless, more chemically stable, and more water-compatible than the parent curcumin molecule, which degrades at physiological pH. This stability advantage is a formulation-level rationale for direct supplementation rather than a confirmed clinical advantage.

Supported by Trial 1, Trial 2

May support liver and metabolic function (preclinical)

Tetrahydrocurcumin has been studied in preclinical diabetic and metabolic models for effects on glucose handling, lipid metabolism, and hepatic antioxidant status. Translation to robust human outcomes remains an active area of investigation.

Supported by Trial 1

Mechanism of action

1

Free-radical scavenging by reduced beta-diketone

The saturated beta-diketone in tetrahydrocurcumin retains hydrogen-donating capacity for direct radical scavenging while removing the conjugated olefinic system of curcumin, contributing to a distinctive antioxidant profile demonstrated in preclinical models.

2

Modulation of inflammatory transcription factors

Preclinical studies show THC modulates NF-κB and other inflammatory transcription factors and downstream cytokines such as TNF-α and IL-6, contributing to its observed anti-inflammatory profile relative to other curcuminoids in cell-based work.

3

Endogenous gut metabolite of curcumin

THC is the major in vivo reductive metabolite of curcumin generated by gut microbiota and intestinal enzymes; some of curcumin's clinical effects may in fact be mediated by THC formed enterically, motivating interest in direct THC supplementation.

Clinical trials

1
Tetrahydrocurcumin in Streptozotocin-Nicotinamide Diabetic Rats — Antioxidant Effects

Preclinical study in streptozotocin-nicotinamide induced diabetic rats evaluating the antioxidant effects of tetrahydrocurcumin on lipid peroxidation and antioxidant enzyme activity.

Streptozotocin-nicotinamide diabetic rat model; preclinical.

Tetrahydrocurcumin reduced lipid peroxidation and improved antioxidant enzyme activity in diabetic rats, supporting an antioxidant role for THC in metabolic stress. Preclinical evidence — direct human RCT translation is limited.

2
Differential Anti-Inflammatory Action of Curcuminoids and Turmerones

Mechanistic comparison of curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin, and turmerones on anti-inflammatory and anti-proliferative responses through ROS-independent mechanisms.

Cell-based mechanistic study; preclinical.

Curcumin and its analogs including tetrahydrocurcumin differentially regulate anti-inflammatory and anti-proliferative responses through ROS-independent mechanisms, supporting THC's distinctive role within the curcuminoid family.

Side effects and drug interactions

Common Potential side effects

Limited human clinical safety data specific to direct tetrahydrocurcumin supplementation.
Generally well tolerated in preclinical models at studied doses.
Mild gastrointestinal discomfort possible by analogy to curcumin.
Theoretical caution in active gallbladder disease, mirroring curcumin.
Not extensively studied in pregnancy, lactation, or pediatric populations.

Important Drug interactions

Anticoagulants and antiplatelet drugs (warfarin, clopidogrel) — theoretical platelet effects by analogy to curcumin; monitor.
Antidiabetic medications (insulin, sulfonylureas) — theoretical additive glucose-lowering effects; monitor blood sugar.
CYP-substrate medications — limited human pharmacokinetic data; discuss combined use with clinician.
High-dose curcumin or other curcuminoid products — overlapping mechanism; combine cautiously.

More Antioxidant Ingredients

Antioxidant
AstaZine® (Natural Astaxanthin from Haematococcus pluvialis — BGG)
AstaZine® is BGG's premium natural astaxanthin from Haematococcus pluvialis microalgae — d…
Antioxidant
Green Tea
Green tea extract, derived from Camellia sinensis leaves, is rich in antioxidants like cat…
Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…
Antioxidant
Lutein
Lutein is a yellow carotenoid antioxidant that plays a key role in eye health, particularl…

Explore Other Ingredients

Antioxidant
Alpha Lipoic Acid
Alpha-lipoic acid (ALA) is a versatile antioxidant made naturally in the body that is unus…
Antioxidant
Setria® Glutathione
Setria® is Kyowa Hakko's patented reduced L-glutathione (GSH) produced via fermentation —…
Antioxidant
Milk Thistle
Milk thistle, derived from the Silybum marianum plant, contains silymarin, a compound know…

Frequently asked questions about Tetrahydrocurcumin (THC, 'White Curcumin')

What is tetrahydrocurcumin?

Tetrahydrocurcumin is a colorless metabolite of curcumin that the body naturally produces from turmeric. It is studied as an antioxidant and skin-brightening compound, and some consider it a more stable curcumin derivative.

Is tetrahydrocurcumin better than curcumin?

It is one of the active forms curcumin becomes in the body, and it may have strong antioxidant activity and better stability. Research is still emerging, so it is not clearly superior; standard curcumin (with absorption enhancers) remains the better-studied option.

What is tetrahydrocurcumin used for?

It is used for antioxidant support and, notably, in skincare for a brightening, even-tone effect. As a supplement it is marketed similarly to curcumin, for inflammatory and antioxidant support.

Is tetrahydrocurcumin safe?

Like curcumin, it is generally well tolerated. Curcumin compounds can mildly affect blood clotting and interact with some drugs, so check with your doctor if you take blood thinners or other medications.

What is the recommended dosage of Tetrahydrocurcumin?

The clinically studied dose is Human dosing not well established; literature commonly references 100-500 mg/day equivalents, though robust human dose-finding RCTs are lacking. Always follow the product label and check with a healthcare provider for personal advice.

Is Tetrahydrocurcumin safe, and does it have side effects?

For most healthy adults, Tetrahydrocurcumin is well tolerated at studied doses. Reported effects can include: Limited human clinical safety data specific to direct tetrahydrocurcumin supplementation. Generally well tolerated in preclinical models at studied doses. It may also interact with some medications. Tetrahydrocurcumin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Tetrahydrocurcumin interact with any medications?

Possible interactions include: Anticoagulants and antiplatelet drugs (warfarin, clopidogrel) — theoretical platelet effects by analogy to curcumin; monitor. Antidiabetic medications (insulin, sulfonylureas) — theoretical additive glucose-lowering effects; monitor blood sugar. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Tetrahydrocurcumin?

NutraSmarts rates the evidence for Tetrahydrocurcumin as Limited (2 out of 5). It is backed by 2 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Murugan P, Pari L. Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sci. 2006;79(18):1720-8. doi: 10.1016/j.lfs.2006.06.001.PubMedUsed to support: Foundational preclinical study — tetrahydrocurcumin reduced lipid peroxidation and improved antioxidant enzyme activity in streptozotocin-nicotinamide diabetic rats, supporting THC's antioxidant role in metabolic stress. Preclinical only; not a human RCT.
  2. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28(8):1765-73. doi: 10.1093/carcin/bgm123.PubMedUsed to support: Mechanistic preclinical comparison — curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through ROS-independent mechanisms. Cell-based work; underpins THC's distinct anti-inflammatory profile within the curcuminoid family.
  3. Murugan P, Pari L. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. J Ethnopharmacol. 2007;113(3):479-86. doi: 10.1016/j.jep.2007.07.004.PubMedUsed to support: Follow-up preclinical study — tetrahydrocurcumin influenced erythrocyte membrane-bound enzymes and antioxidant status in experimental type 2 diabetic rats. Reinforces antioxidant positioning under metabolic stress; preclinical only.